Pharmacological characterization of recombinant human and rat P2X receptor subtypes
- 1 July 1999
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 376 (1-2) , 127-138
- https://doi.org/10.1016/s0014-2999(99)00350-7
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Is there a basis for distinguishing two types of P2-purinoceptor?Published by Elsevier ,2002
- A P2X purinoceptor cDNA conferring a novel pharmacological profilePublished by Wiley ,2000
- Properties of the pore‐forming P2X7 purinoceptor in mouse NTW8 microglial cellsBritish Journal of Pharmacology, 1997
- Receptors responsive to extracellular pyrimidine nucleotidesTrends in Pharmacological Sciences, 1997
- Inhibition of ecto‐ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophagesBritish Journal of Pharmacology, 1996
- P2-purinoceptor antagonists: III. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suraminNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1996
- Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channelsJournal of Neuroscience, 1996
- Role of the Purinergic P2Z Receptor in Spontaneous Cell Death in J774 Macrophage CulturesBiochemical and Biophysical Research Communications, 1996
- A P2X purinoceptor expressed by a subset of sensory neuronsNature, 1995
- New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptorNature, 1994